These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26490357)

  • 21. Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
    Bosilkovska M; Déglon J; Samer C; Walder B; Desmeules J; Staub C; Daali Y
    Bioanalysis; 2014 Jan; 6(2):151-64. PubMed ID: 24423593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes be Used in the Rat for Drug Interaction Studies?
    Magalhães P; De Andrés F; Falcão A; LLerena A; Alves G
    J Pharm Pharm Sci; 2016; 19(4):520-529. PubMed ID: 28057170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
    Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
    Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling.
    Shida S; Utoh M; Murayama N; Shimizu M; Uno Y; Yamazaki H
    Xenobiotica; 2015; 45(10):881-6. PubMed ID: 26075833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
    Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
    J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach.
    Zhuang Y; de Vries DE; Xu Z; Marciniak SJ; Chen D; Leon F; Davis HM; Zhou H
    J Clin Pharmacol; 2015 Dec; 55(12):1386-94. PubMed ID: 26054042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs.
    Zheng L; Lu Y; Cao X; Huang Y; Liu Y; Tang L; Liao SG; Wang AM; Li YJ; Lan YY; Wang YL
    J Ethnopharmacol; 2014 Dec; 158 Pt A():276-82. PubMed ID: 25446640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a bupropion, dextromethorphan, and omeprazole cocktail for simultaneous phenotyping of cytochrome P450 2B11, 2D15, and 3A12 activities in dogs.
    Martinez SE; Jimenez TEP; Court MH
    Am J Vet Res; 2024 Jul; 85(7):. PubMed ID: 38718826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus).
    Uehara S; Inoue T; Utoh M; Toda A; Shimizu M; Uno Y; Sasaki E; Yamazaki H
    Xenobiotica; 2016; 46(2):163-8. PubMed ID: 26114209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated administration of berberine inhibits cytochromes P450 in humans.
    Guo Y; Chen Y; Tan ZR; Klaassen CD; Zhou HH
    Eur J Clin Pharmacol; 2012 Feb; 68(2):213-7. PubMed ID: 21870106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.
    Han YL; Li D; Ren B; Jing GP; Meng XL; Zhou ZY; Yu Q; Li Y; Wan LL; Guo C
    J Ethnopharmacol; 2012 Jan; 139(1):104-9. PubMed ID: 22079696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous analysis of cytochrome P450 probes-dextromethorphan, flurbiprofen and midazolam and their major metabolites by HPLC-mass-spectrometry/fluorescence after single-step extraction from plasma.
    Kumar A; Mann HJ; Remmel RP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):287-93. PubMed ID: 17452028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.
    Koyanagi T; Nakanishi Y; Murayama N; Yamaura Y; Ikeda K; Yano K; Uehara S; Utoh M; Kim S; Uno Y; Yamazaki H
    Xenobiotica; 2015 Apr; 45(4):312-21. PubMed ID: 25364857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes.
    Jerdi MC; Daali Y; Oestreicher MK; Cherkaoui S; Dayer P
    J Pharm Biomed Anal; 2004 Sep; 35(5):1203-12. PubMed ID: 15336365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach.
    Fuhr U; Jetter A; Kirchheiner J
    Clin Pharmacol Ther; 2007 Feb; 81(2):270-83. PubMed ID: 17259951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects.
    Kakuda TN; Van Solingen-Ristea RM; Onkelinx J; Stevens T; Aharchi F; De Smedt G; Peeters M; Leopold L; Hoetelmans RM
    J Clin Pharmacol; 2014 Apr; 54(4):422-31. PubMed ID: 24165884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited Sampling Modeling for Estimation of Phenotypic Metrics for CYP Enzymes and the ABCB1 Transporter Using a Cocktail Approach.
    Coelho EB; Cusinato DAC; Ximenez JP; Lanchote VL; Struchiner CJ; Suarez-Kurtz G
    Front Pharmacol; 2020; 11():22. PubMed ID: 32174823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.